Barrow, Hanley, Mewhinney & Strauss’s Chimera Investment CIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-685
Closed -$8.79K – 331
2025
Q1
$8.79K Hold
685
– – ﹤0.01% 225
2024
Q4
$9.6K Hold
685
– – ﹤0.01% 234
2024
Q3
$10.8K Hold
685
– – ﹤0.01% 224
2024
Q2
$8.77K Buy
685
+49
+8% +$621 ﹤0.01% 220
2024
Q1
$8.8K Buy
+636
New +$8.86K ﹤0.01% 213
2022
Q2
– Sell
-264
Closed -$10K – 307
2022
Q1
$10K Sell
264
-2,668
-91% -$106K ﹤0.01% 190
2021
Q4
$133K Hold
2,932
– – ﹤0.01% 195
2021
Q3
$131K Hold
2,932
– – ﹤0.01% 175
2021
Q2
$132K Sell
2,932
-1,692
-37% -$70.4K ﹤0.01% 175
2021
Q1
$176K Buy
+4,624
New +$158K ﹤0.01% 174

Other funds holding CIM

Barrow, Hanley, Mewhinney & Strauss's CIM Position: Q2 2025 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of Chimera Investment (CIM) in Q2 2025, closing a stake of 685 shares — an estimated $8.79K sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in CIM in Q1 2021 and held it in 10 quarters. The position peaked at $176K in Q1 2021. 206 funds tracked by Wall St. Rank hold CIM as of Q2 2025.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining Chimera Investment position as of Q2 2025 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 685 Chimera Investment shares in Q2 2025, an estimated $8.79K.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Chimera Investment in Q1 2021 and held it in 10 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's Chimera Investment position peaked at $176K in Q1 2021.
  • 206 funds tracked by Wall St. Rank held Chimera Investment as of Q2 2025.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2025, filed 12 Aug 2025.